FRDD

Forensically-Relevant Drug Database

NPS Discover

Description

Preferred Drug Name

Ethylbromazolam

Brief Description

Ethylbromazolam is a designer benzodiazepine and is structurally similar to other known triazolobenzodiazepines (e.g., bromazolam, flubromazolam, phenazolam). Ethylbromazolam has been previously reported in drug materials in Australia and New Zealand.1-3 Ethylbromazolam was first identified by our laboratory in July 2025 and confirmed after acquiring standard reference material.

Structure


Nomenclature

Formal Name (IUPAC)

8-bromo-1-ethyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine

Identifiers

CAS Numbers

105470-75-5

Chemistry

Chemical Formula

C18H15BrN4

Molecular Mass

367.20

Molecular Ion

366

Exact Mass

367.0553

SMILES

BrC1=CC=C(C2=C1)N3C(CN=C2C4=CC=CC=C4)=NN=C3CC

InChI String

InChI=1S/C18H15BrN4/c1-2-16-21-22-17-11-20-18(12-6-4-3-5-7-12)14-10-13(19)8-9-15(14)23(16)17/h3-10H,2,11H2,1H3

InChI Key

DKTGBMWWLATMHK-UHFFFAOYSA-N

GCMS Analytics

Lab

CFSRE (Willow Grove, PA)

Comments

Sample Preparation:

Drug Materials: Dilution in methanol or acid / base extraction

Drug Standards: Dilution in methanol

Instrument:Agilent 5975 Series GC/MSD System
Column:Agilent J&W DB-1 (12 m x 200 µm x 0.33 µm)
Carrier Gas:Helium (Flow: 1.46 mL/min)
Temperatures:

Injection Port: 265 °C

Transfer Line: 300 °C

MS Source: 230 °C

MS Quad: 150 °C

Oven Program: 50 °C for 0 min, 30 °C/min to 340 °C for 2.3 min

Injection Parameters:Injection Type: Splitless, Injection Volume: 1 µL
MS Parameters:Mass Scan Range: 40-550 m/z

 

Images

Fragments

204
323
337

HRMS Analytics

Lab

CFSRE (Willow Grove, PA)

Comments

Sample Preparation:

Toxicology Samples: Liquid-liquid extraction

Drug Materials: Dilution of sample in mobile phase

Instrument:

Sciex TripleTOF® 5600+, Shimadzu Nexera XR UHPLC

Sciex X500R, Sciex ExionLC

Column:Phenomenex® Kinetex C18 (50 mm x 3.0 mm, 2.6 µm)
Mobile Phase:

A: Ammonium formate (10 mM, pH 3.0)

B: Methanol/acetonitrile (50:50)

Flow rate: 0.4 mL/min

Gradient:Initial: 95A:5B; 5A:95B over 13 min; 95A:5B at 15.5 min
Temperatures:

Autosampler: 15 °C

Column Oven: 30 °C

Source Heater: 600 °C

Injection Parameters:Injection Volume: 10 µL
QTOF Parameters:

TOF MS Scan Range: 100-510 Da

Precursor Isolation: SWATH® acquisition (27 windows)

Fragmentation: Collison Energy Spread (35±15 eV)

MS/MS Scan Range: 50-510 Da

 

Images

Fragments

367.0541
339.0356
288.1358
205.0769

Drug Origins and Uses

Drug Origins and Uses

Illicit, Synthetic

Biological Effects

Biological Effects

Anxiolytic, Muscle Relaxation, Sedative/Hypnotic

Target Receptor or Neurotransmitter

Target Receptor or Neurotransmitter

GABA

Pharmacodynamics

Pharmacodynamics

Modulator

Drug Control

US Controlled Substance Schedule

Not Controlled


Pharmacology Literature

Source

High Alert

Title

New benzodiazepine ethylbromazolam detected in New Zealand

Reference Link


Source

World Health Organization

Title

Critical review report: Bromazolam

Reference Link


Analytical Literature

Source

Talking Drugs

Title

Ethylbromazolam – The New Global Benzodiazepine

Reference Link


Source

The Know

Title

Ethylbromazolam found in expected alprazolam pills

Reference Link


Published January 27, 2026